Mean hospitalizations per month decreased, but the results did not reach statistical significance ( P = 0.095).
← all excerpts
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States.
1
0.0950
0.0950
Mean hospitalizations per month decreased, but the results did not reach statistical significance ( P = 0.095).